A pioneering Japanese study aims to determine whether the widely used diabetes medication tofogliflozin impacts muscle mass in lean seniors, addressing concerns about potential muscle loss linked to SGLT2 inhibitor treatment in older patients without obesity. Japanese researchers have launched…
Emerging research suggests that GLP-1 receptor agonists may offer protective benefits against fragility fractures, particularly in people with obesity or type 2 diabetes, challenging previous concerns about weight-loss medications weakening bones. New research presented at the American Orthopaedic Foot &…
Roche’s experimental drug enicepatide demonstrates strong efficacy in reducing blood sugar and body weight in adults with type 2 diabetes and obesity, strengthening its position in the competitive metabolic market. Roche has reported encouraging Phase II results for enicepatide, its…
Argentina’s medicines regulator has authorised a 7.2 mg weekly dose of semaglutide, expanding options for personalised obesity management amid promising trial results and ongoing safety assessment. Argentina’s medicines regulator has approved a higher weekly dose of semaglutide for adults with…
A recent study reveals that the serious complication of ketoacidosis linked to SGLT2 inhibitors can continue to pose risks for patients with type 2 diabetes, even after months of therapy, prompting calls for ongoing patient monitoring and management strategies. A…
Encellin has teamed up with Breakthrough T1D to advance its immune-protected cell therapy programme, securing $2.5 million funding to propel clinical development of a novel implant designed to shield insulin-producing cells from immune rejection in type 1 diabetes patients. Encellin…
A common fibre supplement known for relieving constipation is gaining recognition for its broader health benefits, including cholesterol reduction and blood sugar control, as researchers uncover more compelling evidence of its versatility. Psyllium, a low-cost fibre supplement sold in pharmacies,…
A Corpus Christi couple has arranged a partnership with Mattel to deliver up to 10,000 Barbie dolls designed to reflect the reality of children with Type 1 diabetes, aiming to inspire inclusion and awareness nationwide. John and Cheryl Navar, a…
As Jeanne Shaheen nears the end of her Senate tenure, a cross-party effort gains momentum to limit insulin out-of-pocket costs amid soaring prices and public health concerns. As her Senate career draws to a close, Jeanne Shaheen is making one…
An internal medicine specialist warns that Turks are consuming four to five times the amount of sugar recommended by the WHO, increasing risks of chronic diseases including diabetes and heart disease. Turkey’s appetite for sugar is far above global health…
